Joysoual, M.R. et al. 2023. Efficacy of Empagliflozin as Add-on Therapy in Patients with Uncontrolled Type 2 Diabetes Mellitus. TAJ: Journal of Teachers Association. 36, 1 (Aug. 2023), 89–95. DOI:https://doi.org/10.3329/taj.v36i1.68304.